Synopsis * Data4Cure introduces the CRISPR Cancer Immune Atlas, featuring data from recent publications that utilize CRISPR technology to uncover key determinants of cancer immunity. * The CRISPR Cancer Immune Atlas offers 71 screens across 10 datasets, including data from in vitro and in vivo immune challenges as well as phenotypic screens

* Biomarker discovery in Parkinson's disease (PD) is challenging due to late-stage symptom emergence and limited access to high-quality datasets. * The Biomedical Intelligence Cloud offers access to curated datasets, aiding in biomarker identification and drug target discovery for PD. * The Parkinson's disease resource collection in the Biomedical